From: Multi-species bacterial biofilm and intracellular infection in otitis media
 |  |  |  |  | PCR | FISH |  |  | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Child No. | Sex (Age, yr) | Ear | Diagnosis | Current Abx | Culture | Spn | EUB | Spn | Hi | Mcat | Sau | Biofilm | Intracellular bacteria |
Children with recurrent acute otitis media | |||||||||||||
4 | F (1.4) | R | RAOM | N | - | - | + | na | + | + | na | + | + |
5 | M (1.8) | L | RAOM | N | na | na | + | - | + | na | na | - | + |
6 | F (3.2) | L | RAOM | N | na | na | + | na | + | - | na | + | + |
7 | M (6.1) | L | RAOM | N | + mixed | + | + | + | na | - | na | - | + |
8 | F (9.3) | L | RAOM, Cholesteatoma | N | na | na | + | - | na | + | na | - | - |
Children with recurrent acute otitis media and otitis media with effusion | |||||||||||||
9 | M (1.4) | R | RAOM, OME | Y | - | - | + | na | - | + | na | + | + |
10 | M (1.8) | L | RAOM, OME | N | + Spn, Mcat | + | + | + | na | + | na | + | + |
11 | F (1.8) | L | RAOM, OME | Y | - | + | + | - | + | na | na | - | + |
12 | F (3.5) | L | RAOM, OME | N | - | - | - | na | - | - | na | - | - |
13 | M (7.5) | L | RAOM, OME | N | - | - | + | na | + | + | na | + | + |
14 | F (8.9) | L | RAOM, OME | N | na | na | + | + | - | na | na | + | + |
Children with otitis media with effusion | |||||||||||||
15 | M (1.5) | L | OME | N | na | na | + | - | - | na | na | + | - |
16 | F (5.4) | L | OME | N | + CNS | - | + | na | - | + | na | + | + |
17 | F (6.0) | L | OME | N | + Sau | - | + | na | na | - | + | + | + |
18 | F (6.3) | R | OME | N | na | na | - | - | na | - | na | - | - |
19 | F (8.0) | R | OME | N | na | na | + | - | - | na | na | + | - |
20 | M (9.9) | R | OME | N | na | na | + | + | na | + | na | + | + |
Control cochlear implant | |||||||||||||
21 | F (1.6) | L | Sensorineural hearing loss | N | na | na | - | - | - | na | na | - | - |
Positive from number tested (not including healthy control) | 2/17 | 4/9 (44%) | 3/9 (33%) | 15/17 (88%) | 4/10 (40%) | 5/11 (45%) | 7/12 (58%) | 1/1 | 11/17 (64%) | 12/17 (71%) |